Schedule 13G ownership disclosure

BRIACELL THERAPEUTICS ORD

Security class unavailable · CUSIP: 10778Y302

Event date: 2021-06-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-21-015372
Form type
SC 13G
Filer
BriaCell Therapeutics Corp.
CIK
CIK 1610820
Filed
Jun 28, 2021
Reporting period
Jun 21, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub